Member Portal
About ISCTM
Mission Statement and Rationale
Objectives of the Society
Conflict of Interest Policy
ISCTM Strategic Plan
Executive Viewpoint
Committees
2026-2027 Executive Committee
2026-2027 Organizational Committees
Award Recipients
Code of Conduct
Society Amended and Restated Bylaws
Meetings / Activities
ISCTM Session Proposal Submission
2026 Autumn Conference
22nd Annual Scientific Meeting
Meeting Archives
Working Groups
Podcasts
Awards
Webinars
Upcoming Calendar
Related Meetings & Events
Support an ISCTM Meeting
Publications
Membership
Young Investigators
Benefits of Membership
Join/Renew Membership (Individual)
Individual Membership Categories & Dues
Sustaining Corporate Membership
2026 Sustaining Corporate Members
Benefits and Membership Levels
Member Directory
Update Profile
2024 Autumn Conference Posters
Click title to view pdf. Posters are in alpha order by first author.
Measurement of positive and negative symptoms through speech analysis from PANSS interview recordings in patients with schizophrenia
(
Abstract
)
Abbas
Patient ratings from a genetic biomarker guided trial with liafensine support clinician-rated findings in patients with treatment resistant depression
(
Abstract
)
Alphs
Assessing amnestic mild cognitive impairment using smartphone-based ecological momentary cognitive testing: Sensitivity of various performance metrics
(
Abstract
)
Campbell
Capturing changes in positive affect and social functioning using ecological momentary assessment (EMA) in a 12-month treatment trial in schizophrenia
(
Abstract
)
Chaturvedi
Two for the price of one: HAM-D rating variability does not necessarily increase with the number of raters
(
Abstract
)
Cole
Artefact rejection in EEG and quality control
(
Abstract
)
Das
Development of a digital health tool evaluation framework for operational sponsor considerations in clinical trials
(
Abstract
)
DeBonis
Comparing effectiveness of manufacturer-recommended therapeutic ADT dose as detailed in the Antidepressant Treatment Response Questionnaire (ATRQ)
(
Abstract
)
Desjardins
Correcting speaker labeling errors in automated transcripts of clinical conversations
(
Abstract
)
Efstathiadis
Development of the Treatment Attitude Profile (TAP) scale: AI/ML-driven insights for clinical trial enrichment to minimize placebo response
(
Abstract
)
Geraci
Insights from the CATIE schizophrenia trial: AI/ML-driven analysis to identify key variables influencing treatment outcomes
(
Abstract
)
Geraci
Examining negative symptoms and everyday functioning as a correlated time series: Causal analysis of treatment effects in a 12-month open-label study
(
Abstract
)
Harvey
A clinical trial inclusion criteria to enrich for patients presenting with canonical symptom structure in bipolar depression
(
Abstract
)
Hopkins
Longitudinal convergence of dispersed clinical ratings and ecological momentary assessment burst assessments of negative symptoms in schizophrenia
(
Abstract
)
Horan
Functional unblinding evaluation of central raters in a large psychedelic clinical trial
(
Abstract
)
Karas
Equipercentile linking masks data quality concerns in depression clinical trials
(
Abstract
)
Karazsia
Audio and video digital measurements observed in naturalistic settings predict PANSS Marder factor scores in schizophrenia
(
Abstract
)
Kark
Integrating synchronous AI-based fidelity adherence monitoring of facilitators in psychedelic clinical trials
(
Abstract
)
Kelman
The utility of the NIDA Phenotyping Assessment Battery in a combined enrichment strategy for determining eligibility in addiction clinical trials
(
Abstract
)
Keyser-Marcus
Standardized EEG/ERP battery for measuring drug effects in CNS trials using end-to-end automated analytic pipeline
(
Abstract
)
Korolev
Equating CDRS-R and MADRS scale scores in adolescents with major depressive disorder with acute suicidal ideation or behavior
(
Abstract
)
Kosik-Gonzalez
Impact of low-recruiting sites on data quality in early Alzheimer’s disease clinical trials
(
Abstract
)
Kott
Raters associated with erratic ratings differ in their scoring technique
(
Abstract
)
Kott
EEG-based machine learning biomarker to predict treatment response from SSRI and TMS treatment of MDD and TRD patients
(
Abstract
)
Li
Quantifying exposure: Novel methods to investigate exposure treatments for trauma-related nightmares
(
Abstract
)
Medvescek
Central monitoring and data quality assurance identifying and correcting errors in fluency tests in CNS trials
(
Abstract
)
Miller
Prospectively specified adaptive Bayesian borrowing considerations methodologies and implementations
(
Abstract
)
Mukhopadhyay
Analytical validation of a novel quality assurance approach for COAs in Alzheimer’s disease clinical trials
(
Abstract
)
Newsome
Development of a comprehensive guide for navigating information on digital biomarkers in CNS clinical trials
(
Abstract
)
Pendergrass
Evaluating psychotherapeutic components in psychedelic-assisted therapies: A comprehensive review
(
Abstract
)
Price
Insights in psychedelic research – Historical overview
(
Abstract
)
Rundle
Reference ranges of healthy brain network activity to inform CNS treatment development
(
Abstract
)
Setton
Differences in detected error rate and resolution between clinical data validation and video review in Phase III clinical trials
(
Abstract
)
Steele
Enhancing speech analysis through de-hallucination and LLM diarization in physician-patient interviews
(
Abstract
)
Tomioka
Search Posters
Not a Member Yet?
Some of the member benefits you could be receiving: Discounted Registration Fees; Access to the DocMatter Community; Access to archived meeting materials; Participation in ISCTM Working Groups
Join Today
